Nomura Asset Management »

BioMarin Pharmaceutical shares owned by Nomura Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Nomura Asset Management from 13F filings

Historical chart of Nomura Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Nomura Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Nomura Asset Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $623k 10k 62.30

More positions owned by Nomura Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Intel Corporation (INTC)
Micron Technology (MU)

View all positions for Nomura Asset Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical